Latest filing published 11 Dec 2023 for Fresh Tracks Therapeutics, Inc., €8,577.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Deepak Chadha: trading record in brief
Deepak Chadha (senior executive) discloses dealings in Fresh Tracks Therapeutics, Inc. to SEC (Form 4). Between 22 June 2020 and 1 September 2023, the trades on record add up to 7 filings.
No open-market sale appears; the market trades are 3 purchases worth €10k. The totals do not cover 1 filing with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 2 share grants and 2 option exercises.
Most recently, on 11 December 2023, the filings show a share grant worth €8,577 in Fresh Tracks Therapeutics, Inc. The clock since the last published purchase (19 May 2021) now reads 2,000 days. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Deepak Chadha
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 14,978 shares@ US$0.62131.4% of flowCommon StockSEC:0001628280-23-041230:1
- 35,000 sharesCommon StockSEC:0001628280-23-041230:0
- 12,500 shares@ US$0.830245.6% of flowCommon StockSEC:0001062993-21-004866:1Canonical exit: 17 Aug 2021 (T+90)
- 2,700 shares@ US$0.8191100.0% of flowCommon StockSEC:0001062993-21-004866:0Canonical exit: 16 Aug 2021 (T+90)
- 25,000 sharesCommon StockSEC:0001062993-21-002791:0
- 8,750 shares@ US$1.1444.7% of flowCommon StockSEC:0001062993-21-002791:1
- 26,087 sharesCommon StockSEC:0000911916-20-000135:0Canonical exit: 20 Sept 2020 (T+90)
7 of 7 declarations
